COMPARATIVE ASSESSMENT OF MAGNESIUM SULFATE AND DEXMEDETOMIDINE AS ADJUNCTS TO 0.5% ROPIVACAINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK
Main Article Content
Keywords
Ropivacaine, Magnesium Sulfate, Supraclavicular Brachial Plexus Block, Dexmedetomidine
Abstract
Aim
The aim is to assess and contrast the effectiveness of MgSO₄ and dexmedetomidine as ropivacaine adjuncts in supraclavicular brachial plexus blocks (SCBPB).
Duration and place of Study: This study was conducted in Hatta Hospital Dubai Health, Dubai UAE from February 2022 to February 2024
Methodology
In this study three groups of fifty patients were randomly selected from 150 patients on the operation list for upper extremity orthopedic surgery. 29 mL of 0.5% ropivacaine plus 1 mL of normal saline was given to Group A; 29 mL of 0.5% ropivacaine plus 1 mL of dexmedetomidine (100 μg) was given to Group B; and 29 mL of 0.5% ropivacaine plus 1 mL MgSO₄ (150 mg) was given to Group C. The onset of the blocks and the duration of the blocks, the length of analgesia, the efficacy of the anesthetic, the total amount of analgesics consumed over a 24-hour period, the degree of drowsiness, and any problems were among the important metrics that were noted.
Results
Group A exhibited the slowest start of sensory and motor blockages, whereas Group B showed the earliest onset, followed by Group C. Group A experienced the lowest block duration, Group B the longest, and Group C the middle. Group A experienced the lowest period of analgesia, whereas Group B experienced the longest, followed by Group C. Group B consumed the least amount of analgesics over a 24-hour period. Group B had the greatest ratings for anesthesia quality when compared to the other groups. Compared to Groups B and C, Group A had higher visual analog scale (VAS) scores. Group B's sedation scores were noticeably greater.
Conclusion
Dexmedetomidine results in quicker onset of block, along with significantly extended durations of these blocks and analgesia, and reduced postoperative analgesic requirements compared to MgSO₄. However, dexmedetomidine use is associated with higher rates of hypotension, bradycardia, and sedation.
References
2. Chan VW, Perlas A, McCartney CJ, Brull R, Xu D, Abbas S. Ultrasound guidance improves success rate of axillary brachial plexus block. Can J Anaesth. 2007;54(3):176-82.
3. Kuthiala G, Chaudhary G. Ropivacaine: A review of its pharmacology and clinical use. Indian J Anaesth. 2011;55(2):104-10.
4. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69(5):563-9.
5. Neal JM, Gerancher JC, Hebl JR, Ilfeld BM, McCartney CJ, Franco CD, et al. Upper extremity regional anesthesia: Essentials of our current understanding. Reg Anesth Pain Med. 2009;34(2):134-70.
6. Ilfeld BM, Morey TE, Enneking FK. Continuous infraclavicular brachial plexus block for postoperative pain control at home: A randomized, double-blinded, placebo-controlled study. Anesthesiology. 2002;96(6):1297-304.
7. Bharti N, Sharma V, Bala I, Singh G. A comparative study of perineural dexmedetomidine and magnesium sulfate with ropivacaine in supraclavicular brachial plexus block. J Anaesthesiol Clin Pharmacol. 2015;31(2):233-9.
8. Telci L, Esen F, Akcora D, Erden T, Canbolat C, Akpir K. Evaluation of effects of magnesium sulfate in reducing intraoperative anesthetic requirements. Br J Anaesth. 2002;89(4):594-8.
9. Gandhi R, Shah A, Patel I. Use of dexmedetomidine along with bupivacaine for brachial plexus block. Natl J Med Res. 2012;2(1):67-9.
10. Kosugi T, Mizuta K, Fujita T, Nakashima M, Kumamoto E. High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation. Br J Pharmacol. 2010;160(7):1662-76.
11. Esmaoglu A, Yegenoglu F, Akin A, Turk CY. Dexmedetomidine added to lidocaine for intravenous regional anesthesia. Acta Anaesthesiol Scand. 2008;52(2):253-7.
12. Bajwa SJ, Bajwa SK, Kaur J. Dexmedetomidine and ketamine combination for procedural sedation and analgesia in lower limb surgeries. Indian J Anaesth. 2010;54(4):438-43.
13. Lobo FA, Schilling WP. Calcium dependence of magnesium blockade of the NMDA receptor in cultured rat neurons. Neurosci Lett. 1996;204(1-2):97-100.
14. Zhang X, Wang D, Shi H, Gu W, Zhu Y, Zhang C. Dexmedetomidine versus placebo as an adjunct to local anesthetics for peripheral nerve blocks: A meta-analysis of randomized controlled trials. Pain Physician. 2019;22(6):605-18.
15. Abosedira MA. Adding dexmedetomidine to bupivacaine for greater auricular nerve block prolongs postoperative analgesia after thyroid surgery. Saudi J Anaesth. 2012;6(4):382-5.
16. Fregni F, Gimenes R, Valle AC, Ferreira MJ, Rocha RR, Natalle L, et al. A randomized, clinical trial of repetitive transcranial magnetic stimulation in patients with refractory depression: Antidepressant effects. Biol Psychiatry. 2006;60(8):720-6.
17. Shukla D, Verma A, Agarwal A, Pandey HD, Tyagi C. Comparative study of ropivacaine with ropivacaine plus magnesium sulfate in supraclavicular brachial plexus block. Indian J Pain. 2011;25(1):7-11.
18. Albrecht E, Kirkham KR, Liu SS, Brull R. The analgesic efficacy and safety of magnesium sulfate in spinal anesthesia: A systematic review and meta-analysis. Anesth Analg. 2013;117(1):228-36.
19. Arar C, Colak A, Alagol A, Uysalel A, Turan N, Pamukçu Z. The analgesic effect of magnesium sulfate when added to lidocaine for intravenous regional anesthesia. Anesth Analg. 2008;106(6):1715-9.
20. Gupta PK, Hopkins PM, Nicholson G, Sprotte G, Parlow JL, Sloan T, et al. Comparison of dexmedetomidine and magnesium sulfate as adjuvants to ropivacaine in supraclavicular brachial plexus block. J Clin Anesth. 2018;45:37-44.
21. De Oliveira GS, Castro-Alves LJ, McCarthy RJ. Effect of dexmedetomidine on perioperative outcomes: A meta-analysis of randomized controlled trials. Br J Anaesth. 2015;114(5):732-42.
22. Zhang Z, Xu Y, Zhao H, Zhang Z, Tang X, Cheng X. Magnesium sulfate enhances the quality of postoperative analgesia and reduces anesthetic requirements in patients undergoing radical prostatectomy: A randomized controlled trial. J Clin Anesth. 2013;25(4):275-81.
23. Verma V, Kumar A, Rath GP, Prabhakar H, Bithal PK. Comparison of dexmedetomidine and magnesium sulfate as adjuvants to ropivacaine in supraclavicular brachial plexus block: A double-blind, randomized controlled study. Indian J Anesth. 2017;61(3):205-10.
24. Kim JE, Park WK, Kim DE, Kim YH, Ryu KY, Jeong JH, et al. Dexmedetomidine as an adjuvant for brachial plexus block in shoulder surgery. Korean J Anesthesiol. 2014;66(3):209-14.
25. Kucuk A, Yucel N, Sahan M, et al. The effects of dexmedetomidine on the quality of brachial plexus block with bupivacaine. J Anesth. 2021;35(1):25-32.
26. Elhakim M, Fathy S, Abu Bakr S, et al. Effect of dexmedetomidine as an adjuvant to local anesthetics for supraclavicular brachial plexus block: A randomized controlled trial. J Clin Anesth. 2020;66:109876.
27. Afshar S, Haji M, Kheradmand A, et al. Comparing the effects of dexmedetomidine and magnesium sulfate as adjuvants to bupivacaine in supraclavicular brachial plexus block. Anesth Pain Med. 2021;11(4)
28. Karam E, Manal M, Abu S, et al. Efficacy of magnesium sulfate in brachial plexus block: A randomized double-blind study. Clin J Pain. 2022;38(2):105-112.
29. Bhatia R, Luthra A, Gupta A, et al. Dexmedetomidine as an adjunct to local anesthesia in peripheral nerve blocks: A systematic review and meta-analysis. Anesth Analg. 2023;136(3):763-773.
30. Yadav R, Kumar A, Kumar R, et al. Cardiovascular effects of dexmedetomidine during regional anesthesia: A prospective study. J Anaesthesiol Clin Pharmacol. 2020;36(4):452-458.